Securing the Future: Onshoring Pharmaceutical Manufacturing and GMP Labeling's Role in Enhancing National Security and Supply Chain Resilience
The risk of manufacturing pharmaceuticals overseas was known well before the outset of COVID-19 in 2020. The FDA reported that as of 2019, only 28% of active pharmaceutical ingredients (APIs) supplied
… read more